Randall-Type Monoclonal IgE Kappa Light-Heavy Chain Deposition Disease

[1]  S. Nasr,et al.  Monoclonal Gammopathy of Renal Significance. , 2021, The New England journal of medicine.

[2]  H. C. Beck,et al.  Immunoelectron microscopy and mass spectrometry for classification of amyloid deposits , 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[3]  B. Knebelmann,et al.  Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study. , 2019, Blood.

[4]  A. D’Souza.  Monoclonal Gammopathy of Renal Significance , 2018 .

[5]  M. Cogné,et al.  Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management. , 2017, Kidney international.

[6]  R. LeBlanc,et al.  IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometry. , 2015, Journal of the American Society of Nephrology : JASN.

[7]  V. D’Agati,et al.  Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[8]  J. Sedor.  Tissue proteomics: a new investigative tool for renal biopsy analysis. , 2009, Kidney international.

[9]  R. Hegele,et al.  Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. , 1993, The New England journal of medicine.

[10]  J. Kearney,et al.  Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein , 1987, The Journal of cell biology.

[11]  M. Y. Tung,et al.  Manifestations of systemic light chain deposition. , 1976, The American journal of medicine.

[12]  Terry M Therneau,et al.  Review of 1027 patients with newly diagnosed multiple myeloma. , 2003, Mayo Clinic proceedings.